Skip to main content
Vineet Laboratories Limited logo

Vineet Laboratories Limited — Investor Relations & Filings

Ticker · VINEETLAB ISIN · INE505Y01010 LEI · 98450053FEE2D64C6147 BSE.NS Manufacturing
Open in API
Filings indexed 278 across all filing types
Latest filing 2026-05-30 Regulatory Filings
Country IN India
Listing BSE.NS VINEETLAB

About Vineet Laboratories Limited

http://vineetlabs.co.in/

Vineet Laboratories Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and API intermediates. The company focuses on producing high-quality chemical compounds through advanced research and development, catering to diverse therapeutic segments including anti-retroviral, anti-diabetic, and anti-hypertensive treatments. Its core operations involve the synthesis of complex molecules and fine chemicals, supported by manufacturing facilities that adhere to rigorous quality management systems. Vineet Laboratories provides custom synthesis and contract manufacturing services, positioning itself as a technical partner for global healthcare organizations. The company emphasizes process optimization and cost-effective production to deliver reliable chemical solutions for large-scale pharmaceutical applications.

Recent filings

Filing Released Lang Actions
General Updates
Regulatory Filings Classification · 87% confidence The document is an exchange filing under SEBI LODR informing investors of the outcome of a board meeting (specifically the deferment of audited financial results and trading window status) and includes no actual financial statements. It is not a full financial report (10-K, IR, etc.), nor a management discussion or investor presentation. There is no proxy solicitation, dividend notice, or detailed audit opinion. It is a general regulatory/compliance announcement to the stock exchange, which falls under the catch-all Regulatory Filings category (RNS).
2026-05-30 English
Outcome of Board Meeting Held on May 30,2026 Deferment of Consideration of Audited Standalone Financial Results
Regulatory Filings Classification · 79% confidence The document is a company announcement to stock exchanges about the outcome of a Board meeting. It informs regulators of the deferment of consideration of audited financial results, resignation of the Company Secretary/Compliance Officer, and the continued trading window closure. It does not contain the actual financial results, detailed statements, or full report content, nor is it simply a notification that a report is available (RPA). It also isn’t primarily a management explanation of results or a specific transaction notice. This fits the “Regulatory Filings” (RNS) category for general compliance announcements.
2026-05-30 English
Resignation of Director/KMP/SMP
Regulatory Filings
2026-05-30 English
Resignation
Board/Management Information Classification · 86% confidence The document is a formal disclosure to stock exchanges under SEBI LODR Regulation 30 announcing the resignation of the Company Secretary and Compliance Officer (a change in Key Managerial Personnel). It details the cessation date, includes resignation letters, and is clearly an announcement of a senior management change. This matches the Board/Management Information category.
2026-05-29 English
We are hereby submitting the resignation of Company Secretary.
Board/Management Information Classification · 85% confidence The document is a formal disclosure under Regulation 30 of SEBI LODR regarding the resignation of the Company Secretary & Compliance Officer, a key managerial personnel change. This is an announcement of a change in senior management, matching the definition for Board/Management Information.
2026-05-29 English
Vineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve the Audited Standalone ....
Regulatory Filings Classification · 20% confidence The document is a formal notice to stock exchanges under SEBI Listing Regulations informing about the date of the board meeting to consider and approve audited financial results. It does not contain the results themselves, nor is it announcing any change in directors or management. It is not a proxy or AGM material, nor a dividend notice or financial report. This falls under miscellaneous regulatory announcements and thus is best classified as a Regulatory Filing (RNS) as a notice under SEBI regulations.
2026-05-26 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.